Tupper Colleen - Net Worth and Insider Trading

Tupper Colleen Net Worth

The estimated net worth of Tupper Colleen is at least $2 Million dollars as of 2023-03-22. Tupper Colleen is the EVP & CFO of Collegium Pharmaceutical Inc and owns about 90,304 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Details can be seen in Tupper Colleen's Latest Holdings Summary section.

Transaction Summary of Tupper Colleen


Tupper Colleen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tupper Colleen owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .

Click here to see the complete history of Tupper Colleen’s form 4 insider trades.

Insider Ownership Summary of Tupper Colleen

Ticker Comapny Transaction Date Type of Owner
COLL Collegium Pharmaceutical Inc 2022-02-10 EVP & Chief Financial Officer

Tupper Colleen Latest Holdings Summary

Tupper Colleen currently owns a total of 1 stock. Tupper Colleen owns 90,304 shares of Collegium Pharmaceutical Inc (COLL) as of October 4, 2022, with a value of $2 Million.

Latest Holdings of Tupper Colleen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2022-10-04 90,304 24.89 2,247,667

Holding Weightings of Tupper Colleen

Tupper Colleen Form 4 Trading Tracker

According to the SEC Form 4 filings, Tupper Colleen has made a total of 1 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 4,350 shares on October 4, 2022, which brought Tupper Colleen around $75,473.

Insider Trading History of Tupper Colleen

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Collegium Pharmaceutical Inc
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tupper Colleen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tupper Colleen Ownership Network

Ownership Network List of Tupper Colleen

No Data

Ownership Network Relation of Tupper Colleen

Tupper Colleen Owned Company Details

What does Collegium Pharmaceutical Inc do?

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Who are the key executives at Collegium Pharmaceutical Inc?

Tupper Colleen is the EVP & Chief Financial Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and Chief Medical Officer Richard Malamut , and EVP & Chief Commercial Officer Scott Dreyer .

Collegium Pharmaceutical Inc (COLL) Insider Trades Summary

Over the past 18 months, Tupper Colleen made 1 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 4,350. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 164,703 shares made by Joseph Ciaffoni , a net sale of 298,612 shares made by Michael Thomas Heffernan , and a net sale of 60,700 shares made by Shirley R. Kuhlmann .

In summary, during the past 3 months, insiders sold 78,397 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 78,397 shares. During the past 18 months, 562,451 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 562,451 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.


NAS:COLL Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Tupper Colleen Mailing Address

Above is the net worth, insider trading, and ownership report for Tupper Colleen. You might contact Tupper Colleen via mailing address: C/o Collegium Pharmaceutical, Inc., 100 Technology Center Drive, Stoughton Ma 02072.